ABC00095UF

Dolutegravir Enantiomer

Dolutegravir Enantiomer is the non-pharmacologically active stereoisomer of the HIV integrase inhibitor dolutegravir, characterized by the opposite configuration at the chiral center adjacent to the pyrimidin-4(3H)-one scaffold. It retains the 5-(cyclopropylmethyl)-1,3-dihydro-2H-indole-2-one core and trifluoromethyl-substituted phenyl ring but exhibits inverted spatial arrangement of substituents. This enantiomer arises as a synthetic byproduct during asymmetric synthesis and serves as a critical HPLC reference standard for enantiomeric purity analysis in API manufacturing.

On Request
Molecular Formula C20H19F2N3O5
Molecular Weight 419.4000
CAS Number 1309560-49-3 โœ“ Verified
PubChem CID 66594067 โ†—
Purity 95%
Product Type API Impurity
Parent Drug Dolutegravir
Lead Time 14 Days
IUPAC Name (4S,12aR)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1?,2?:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
Official Reference Standards
Std Catalog # Quantity Price
USP 1224961 โ†— โ€” โ€”

๐Ÿ“ Synonyms

1309560-49-3 S3BN9Q9EHW (4S,12aR)-N-((2,4-Difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide dolutegravir S,R RefChem:920608 Dolutegravir SR Isomer UNII-S3BN9Q9EHW Dolutegravir S,R isomer (3R,7S)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide 2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4S,12aR)-

๐Ÿ”ฌ Chemical Identifiers

FC1=C(CNC(=O)C=2C(C(=C3N(C[C@H]4OCC[C@@H](N4C3=O)C)C2)O)=O)C=CC(=C1)F
InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m0/s1
RHWKPHLQXYSBKR-ZUZCIYMTSA-N

Related Products